Prognostic Significance of VEGF and HIF-1 α in Hepatocellular Carcinoma Patients Receiving Sorafenib Versus Metformin Sorafenib Combination
Shereen El Shorbagy, Fouad Abu-Taleb, Hany A. Labib, Huda F. Ebian, Ola A. Harb, Mona Mohammed, Hanaa Rashied, Khaled A. Elbana, Rasha Haggag
Topics & Concepts
SorafenibMedicineHepatocellular carcinomaInternal medicineMetforminOncologyVascular endothelial growth factorVascularityGastroenterologySurgeryVEGF receptorsInsulinMetabolism, Diabetes, and CancerCancer, Hypoxia, and MetabolismBiological Research and Disease Studies